← All verdicts
Verdict

Valuation N/A

Every analyzed stock in Valuation N/A — 479 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Valuation N/A" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
AACBU
AACBU
Valuation N/A
Price$10.70
Model IV—
P/IV—
Limited data — see page
AACIU
Armada Acquisition Corp. III
Valuation N/A
Financial Services
Price$10.14
Model IV—
P/IV—
Limited data — see page
AACIW
Armada Acquisition Corp. III
Valuation N/A
Financial Services
Price$0.24
Model IV—
P/IV—
Limited data — see page
AACOU
Abony Acquisition Corp. I
Valuation N/A
Financial Services
Price$10.06
Model IV—
P/IV—
Limited data — see page
AACOW
Abony Acquisition Corp. I
Valuation N/A
Financial Services
Price$0.42
Model IV—
P/IV—
Limited data — see page
AACPU
Apogee Acquisition Corp
Valuation N/A
Financial Services
Price$10.30
Model IV—
P/IV—
Limited data — see page
ABVEW
ABVEW
Valuation N/A
Price$0.02
Model IV—
P/IV—
Limited data — see page
ACAAU
Averin Capital Acquisition Corp.
Valuation N/A
Financial Services
Price$10.16
Model IV—
P/IV—
Limited data — see page
ACAAW
Averin Capital Acquisition Corp.
Valuation N/A
Financial Services
Price$0.76
Model IV—
P/IV—
Limited data — see page
ACGCU
ACP Holdings Acquisition Corp.
Valuation N/A
Financial Services
Price$10.12
Model IV—
P/IV—
Limited data — see page
ADACU
American Drive Acquisition Co
Valuation N/A
Financial Services
Price$10.23
Model IV—
P/IV—
Limited data — see page
ADACW
American Drive Acquisition Co
Valuation N/A
Financial Services
Price$0.30
Model IV—
P/IV—
Limited data — see page
ADSEW
Ads-Tec Energy Public Ltd Co
Valuation N/A
Technology Risk 35 · Moderate
Price$0.44
Model IV—
P/IV—
Market implies -50.0%/yr vs model +21.8% · below model
AEAQU
Activate Energy Acquisition Corp.
Valuation N/A
Financial Services
Price$10.19
Model IV—
P/IV—
Limited data — see page
AEAQW
Activate Energy Acquisition Corp.
Valuation N/A
Financial Services
Price$0.34
Model IV—
P/IV—
Limited data — see page
AENT
ALLIANCE ENTERTAINMENT HOLDING CORP
Valuation N/A
Industrials Risk 58 · Elevated
Price$5.12
Model IV—
P/IV—
Market implies +100.7%/yr vs model +2.0% · above model
AENTW
ALLIANCE ENTERTAINMENT HOLDING CORP
Valuation N/A
Industrials Risk 35 · Moderate
Price$0.26
Model IV—
P/IV—
Market implies -50.0%/yr vs model +6.0% · below model
AERTW
Aeries Technology, Inc.
Valuation N/A
Industrials Risk 35 · Moderate
Price$0.02
Model IV—
P/IV—
Market implies -50.0%/yr vs model +8.6% · below model
AFJKU
Aimei Health Technology Co., Ltd.
Valuation N/A
Financial Services Risk 32 · Moderate
Price$13.00
Model IV—
P/IV—
Limited data — see page
AIMDW
Ainos, Inc.
Valuation N/A
Technology Risk 32 · Moderate
Price$0.08
Model IV—
P/IV—
Market implies +37.5%/yr vs model +2.0% · above model
AIRJW
AirJoule Technologies Corp.
Valuation N/A
Industrials Risk 37 · Moderate
Price$1.00
Model IV—
P/IV—
Limited data — see page
AKTX
Akari Therapeutics Plc
Valuation N/A
Healthcare Risk 42 · Elevated
Price$11.04
Model IV—
P/IV—
Limited data — see page
ALDFU
Aldel Financial II Inc.
Valuation N/A
Financial Services Risk 62 · High
Price$10.90
Model IV—
P/IV—
Limited data — see page
ALDFW
Aldel Financial II Inc.
Valuation N/A
Financial Services Risk 37 · Moderate
Price$0.26
Model IV—
P/IV—
Limited data — see page
ALISU
Calisa Acquisition Corp
Valuation N/A
Technology Risk 35 · Moderate
Price$10.79
Model IV—
P/IV—
Limited data — see page
ALOVU
Aldabra 4 Liquidity Opportunity Vehicle, Inc.
Valuation N/A
Financial Services
Price$10.06
Model IV—
P/IV—
Limited data — see page
ALOVW
Aldabra 4 Liquidity Opportunity Vehicle, Inc.
Valuation N/A
Financial Services
Price$0.40
Model IV—
P/IV—
Limited data — see page
ALVOW
Alvotech
Valuation N/A
Healthcare Risk 64 · High
Price$0.33
Model IV—
P/IV—
Market implies -50.0%/yr vs model +50.0% · below model
AMKR
AMKOR TECHNOLOGY, INC.
Valuation N/A
Technology Risk 52 · Elevated
Price$51.73
Model IV—
P/IV—
Market implies +27.5%/yr vs model +5.2% · above model
AMZN
AMAZON COM INC
Valuation N/A
Consumer Cyclical Risk 61 · High
Price$248.42
Model IV—
P/IV—
Market implies +39.0%/yr
ANGHW
Anghami Inc
Valuation N/A
Communication Services Risk 46 · Elevated
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr vs model +26.5% · below model
ANSCU
ANSCU
Valuation N/A
Price$11.69
Model IV—
P/IV—
Limited data — see page
ANSCW
ANSCW
Valuation N/A
Price$0.00
Model IV—
P/IV—
Limited data — see page
ANSS
ANSS
Valuation N/A
Price$374.30
Model IV—
P/IV—
Limited data — see page
ANVS
Annovis Bio, Inc.
Valuation N/A
Healthcare Risk 34 · Moderate
Price$1.12
Model IV—
P/IV—
Limited data — see page
APACU
StoneBridge Acquisition II Corp
Valuation N/A
Financial Services
Price$10.40
Model IV—
P/IV—
Limited data — see page
APLMW
Apollomics Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$0.01
Model IV—
P/IV—
Limited data — see page
APXTU
Apex Treasury Corp
Valuation N/A
Financial Services
Price$10.29
Model IV—
P/IV—
Limited data — see page
APXTW
Apex Treasury Corp
Valuation N/A
Financial Services
Price$0.30
Model IV—
P/IV—
Limited data — see page
ARBEW
Arbe Robotics Ltd.
Valuation N/A
Technology Risk 43 · Elevated
Price$0.02
Model IV—
P/IV—
Market implies +15.0%/yr vs model +2.0% · above model
ARCIU
Archimedes Tech SPAC Partners III Co.
Valuation N/A
Financial Services Risk 43 · Elevated
Price$10.40
Model IV—
P/IV—
Limited data — see page
ARCIW
Archimedes Tech SPAC Partners III Co.
Valuation N/A
Financial Services Risk 50 · Elevated
Price$0.41
Model IV—
P/IV—
Limited data — see page
ARCLU
ARC Group Acquisition I Corp.
Valuation N/A
Financial Services
Price$10.22
Model IV—
P/IV—
Limited data — see page
ARQQW
Arqit Quantum Inc.
Valuation N/A
Technology Risk 33 · Moderate
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr vs model +15.0% · below model
ARTCU
Art Technology Acquisition Corp.
Valuation N/A
Financial Services
Price$10.09
Model IV—
P/IV—
Limited data — see page
ARTCW
Art Technology Acquisition Corp.
Valuation N/A
Financial Services
Price$0.32
Model IV—
P/IV—
Limited data — see page
ASPCU
ASPAC III Acquisition Corp.
Valuation N/A
Financial Services
Price$11.99
Model IV—
P/IV—
Limited data — see page
ASPSZ
ALTISOURCE PORTFOLIO SOLUTIONS S.A.
Valuation N/A
Technology Risk 70 · High
Price$0.19
Model IV—
P/IV—
Market implies -50.0%/yr vs model +2.0% · below model
ATHS
Athene Holding Ltd.
Valuation N/A
Financial Services Risk 65 · High
Price$24.64
Model IV—
P/IV—
Limited data — see page
ATIIU
Archimedes Tech SPAC Partners II Co.
Valuation N/A
Financial Services Risk 41 · Elevated
Price$11.51
Model IV—
P/IV—
Limited data — see page
ATIIW
Archimedes Tech SPAC Partners II Co.
Valuation N/A
Financial Services Risk 37 · Moderate
Price$1.32
Model IV—
P/IV—
Limited data — see page
ATLN
ATLANTIC INTERNATIONAL CORP.
Valuation N/A
Technology Risk 66 · High
Price$0.75
Model IV—
P/IV—
Market implies -50.0%/yr vs model +50.0% · below model
AUSI
AURA SYSTEMS INC
Valuation N/A
Technology Risk 37 · Moderate
Price$0.18
Model IV—
P/IV—
Market implies +23.4%/yr vs model +29.1% · below model
AXINU
Axiom Intelligence Acquisition Corp 1
Valuation N/A
Financial Services
Price$10.73
Model IV—
P/IV—
Limited data — see page
BACCU
Blue Acquisition Corp/Cayman
Valuation N/A
Financial Services
Price$10.89
Model IV—
P/IV—
Limited data — see page
BAERW
Bridger Aerospace Group Holdings, Inc.
Valuation N/A
Technology Risk 54 · Elevated
Price$0.15
Model IV—
P/IV—
Market implies -50.0%/yr vs model +38.4% · below model
BAYAU
BAYAU
Valuation N/A
Risk 35 · Moderate
Price$12.00
Model IV—
P/IV—
Limited data — see page
BBCQU
BBCQU
Valuation N/A
Price$10.09
Model IV—
P/IV—
Limited data — see page
BBCQW
Bleichroeder Acquisition Corp. II
Valuation N/A
Financial Services
Price$1.46
Model IV—
P/IV—
Limited data — see page
BBLG
Bone Biologics Corp
Valuation N/A
Healthcare Risk 33 · Moderate
Price$0.55
Model IV—
P/IV—
Limited data — see page